Sep 2026· Journal of Medicinal Chemistry· Vol 69 19, pp.
22355-22369
· 0 citations· 43 references
Medicine
TL;DR
PEP markedly reduces bacterial burden in a murine CTB model and mitigates infection-associated skin pathology and synergistically enhances intracellular Mtb clearance, integrating ROS-mediated eradication with autophagy-dependent bacterial elimination.
Abstract
Cutaneous tuberculosis (CTB), caused by Mycobacterium tuberculosis (Mtb) infection of the skin, remains a global health burden, underscoring the urgent need for more effective drugs and therapeutic strategies. In this study, we discovered a phenothiazine-based derivative, pyridine-embedded phenothiazinium (PEP), as a promising anti-cutaneous tuberculosis agent with potent efficacy both in vitro and in vivo. Upon light illumination, PEP produces abundant reactive oxygen species (ROS), including type I and type II species, enabling direct mycobacterial killing. Beyond its photodynamic bactericidal activity, PEP also functions as a host-directed therapeutic agent by suppressing mTOR signaling and subsequently inducing autophagy in infected host cells. This dual mechanism synergistically enhances intracellular Mtb clearance, integrating ROS-mediated eradication with autophagy-dependent bacterial elimination. Notably, PEP markedly reduces bacterial burden in a murine CTB model and mitigates infection-associated skin pathology. Collectively, our findings unveil the potential of PEP as a promising dual-action therapeutic approach for the efficient treatment of CTB.
Pulmonary tuberculosis remains one of the most prevalent and threatening infectious diseases. Classical anti-tubercular therapy targets essential enzymes of the pathogen Mycobacterium tuberculosis (Mtb), thereby suppressing bacterial growth. However, the emergence of drug-resistant strains necessitates alternative ther...
V. Lobanov, Andréanne Lupien, Anthony Vocat et al.· Journal of Medicinal Chemist...· 0 citations
Tuberculosis (TB) persists partly because
Mycobacterium tuberculosis
(Mtb) occupies macrophages that differ in antimicrobial activity, nutrient use, inflammatory output, and drug exposure. This review examines how macrophage origin and lesion position influence phagosome maturation, responses to membrane damage, xe...
M. Shariq, N. Ehtesham, S. E. Hasnain· Frontiers in Tuberculosis· 0 citations
Tuberculosis (TB) is one of the deadliest infectious diseases worldwide, with complex and incompletely elucidated pathological mechanisms underlying its recalcitrance to cure. In recent years, the pivotal role of extracellular vesicles (EVs) in host-pathogen interactions has garnered increasing attention. This review s...
Wei Wang, Yi-Jia Liang, Qiu-Xia Gao et al.· Extracellular Vesicles and C...· 0 citations
Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (Mtb), remains a significant global health threat. The complete pathogenesis of Mtb infection within the host remains insufficiently elucidated, highlighting the urgent need for research focused on host-directed therapeutic strategies targeting infected...
Seoyeon Jo, Junghwan Lee, Jaewhan Kim et al.· Immunobiology· 0 citations
The rapid rise of antibiotic resistance underscores the urgent need for anti-infective strategies that circumvent classical bactericidal approaches. Host-directed antivirulence therapies, which target host defense pathways or pathogen virulence rather than essential viability, may reduce selection pressure and delay re...
Gen Li, Qiu-Shuang Sheng, Jia-Yang Liu et al.· Autophagy· 0 citations
Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLWH) despite effective antiretroviral therapy (ART), with HIV infection increasing the risk of active TB by 16 to 27-fold. Even among virologically suppressed individuals on ART, the risk remains 4 to 7-fold higher than in HIV-negative...
Chao Xia, Xiao-Bo Fan, Fang Cheng et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.